Seer Inc (SEER) reports a 17% annual revenue increase and significant expansion in instrument installations, despite facing funding uncertainties impacting customer spending.

Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group"), who collectively own nearly 7.5% of the outstanding common stock of Seer, Inc. (NASDAQ: SEER) ( ...

This article first appeared on GuruFocus. Seer Inc (NASDAQ:SEER) is set to release its Q4 2025 earnings on Feb 26, 2026. The consensus estimate for Q4 2025 revenue is $4.60 million, and the earnings ...

Seer, Inc. will announce Q1 2025 financial results on May 13, 2025, with a live webcast at 1:30 PM PT. Seer, Inc., a life sciences company specializing in proteomics, announced that it will release ...

Seer, Inc. will announce Q2 2025 financial results on August 6, 2025, with a webcast at 1:30 PM PT. Seer, Inc. announced that it will release its financial results for the second quarter of 2025 on ...

1 Day SEER -1.42% DJIA 0.65% Russell 2K 0.52% Health Care/Life Sciences 1.51% ...

Good day, and welcome to the Seer, Inc. Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...

REDWOOD CITY, CA - Seer, Inc. (NASDAQ:SEER), a company specializing in laboratory analytical instruments, announced the resignation of Dr. Rachel Haurwitz from its Board of Directors and all ...

REDWOOD CITY, CA - Seer, Inc., a company specializing in laboratory analytical instruments, has executed a repricing of certain employee stock options as disclosed in a recent SEC filing. The Board of ...

REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the ...